Ng, J., Duan, W. R., Marbury, T., Schmidt, J. M., & Klein, C. E. (2019). Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic Impairment. Clinical Pharmacology in Drug Development, 8(8), 1053. https://doi.org/10.1002/cpdd.640
Chicago Style (17th ed.) CitationNg, Juki, W. Rachel Duan, Thomas Marbury, Jeffrey M. Schmidt, and Cheri E. Klein. "Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic Impairment." Clinical Pharmacology in Drug Development 8, no. 8 (2019): 1053. https://doi.org/10.1002/cpdd.640.
MLA (9th ed.) CitationNg, Juki, et al. "Elagolix Pharmacokinetic Profiles in Women With Renal or Hepatic Impairment." Clinical Pharmacology in Drug Development, vol. 8, no. 8, 2019, p. 1053, https://doi.org/10.1002/cpdd.640.